HK1167406A1 - Pyrazolone-derivatives and their use as pd4 inhibitors pd4 - Google Patents

Pyrazolone-derivatives and their use as pd4 inhibitors pd4

Info

Publication number
HK1167406A1
HK1167406A1 HK12108195.2A HK12108195A HK1167406A1 HK 1167406 A1 HK1167406 A1 HK 1167406A1 HK 12108195 A HK12108195 A HK 12108195A HK 1167406 A1 HK1167406 A1 HK 1167406A1
Authority
HK
Hong Kong
Prior art keywords
pyrazolone
inhibitors
derivatives
Prior art date
Application number
HK12108195.2A
Other languages
English (en)
Chinese (zh)
Inventor
Imre Schlemminger
Beate Schmidt
Dieter Flockerzi
Hermann Tenor
Christof Zitt
Armin Hatzelmann
Degenhard Marx
Clemens Braun
Raimund Klzer
Anke Heuser
Hans-Peter Kley
Geert Jan Sterk
Original Assignee
Takeda Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40427227&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1167406(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Gmbh filed Critical Takeda Gmbh
Publication of HK1167406A1 publication Critical patent/HK1167406A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK12108195.2A 2008-11-14 2012-08-21 Pyrazolone-derivatives and their use as pd4 inhibitors pd4 HK1167406A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08169143 2008-11-14
US19333308P 2008-11-19 2008-11-19
PCT/EP2009/065031 WO2010055083A1 (en) 2008-11-14 2009-11-12 Novel pyrazolone-derivatives and their use as pd4 inhibitors

Publications (1)

Publication Number Publication Date
HK1167406A1 true HK1167406A1 (en) 2012-11-30

Family

ID=40427227

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12108195.2A HK1167406A1 (en) 2008-11-14 2012-08-21 Pyrazolone-derivatives and their use as pd4 inhibitors pd4

Country Status (26)

Country Link
US (2) US8609848B2 (ru)
EP (1) EP2356103B1 (ru)
JP (1) JP5599405B2 (ru)
KR (1) KR20110082616A (ru)
CN (1) CN102369194B (ru)
AR (1) AR074318A1 (ru)
AU (1) AU2009315615A1 (ru)
BR (1) BRPI0921335A8 (ru)
CA (1) CA2742922C (ru)
CO (1) CO6331469A2 (ru)
EA (1) EA018585B1 (ru)
EC (1) ECSP11011034A (ru)
ES (1) ES2553754T3 (ru)
GE (1) GEP20135918B (ru)
HK (1) HK1167406A1 (ru)
IL (1) IL212700A0 (ru)
MA (1) MA32885B1 (ru)
ME (1) ME01134B (ru)
MX (1) MX2011005030A (ru)
MY (1) MY154019A (ru)
NZ (1) NZ593262A (ru)
PE (1) PE20110539A1 (ru)
TW (1) TWI460172B (ru)
UA (1) UA105910C2 (ru)
WO (1) WO2010055083A1 (ru)
ZA (1) ZA201102028B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR074318A1 (es) * 2008-11-14 2011-01-05 Nycomed Gmbh Derivados heterociclicos de pirazolona, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades de las vias respiratorias.
US20150322049A1 (en) * 2012-12-13 2015-11-12 Ludwig Aigner Leukotriene pathway antagonists for the treatment of dementia, cognitive deficits in parkinson's disease and/or learning and memory deficiencies in parkinson's disease
WO2017089347A1 (en) 2015-11-25 2017-06-01 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2903460A (en) 1956-04-07 1959-09-08 Sandoz Ag Pyrazolone derivatives
US4550119A (en) 1983-05-23 1985-10-29 Warner-Lambert Company 2,4-Dihydro-5-[(substituted)phenyl]-4,4-disubstituted-3H-pyrazol-3-ones
SK283270B6 (sk) * 1997-01-15 2003-04-01 Altana Pharma Ag Ftalazinóny, farmaceutické prostriedky s ich obsahom a ich použitie
CZ20032491A3 (cs) 2001-02-15 2004-01-14 Altana Pharma Ag Ftalazinonpiperidinové deriváty
EA200301100A1 (ru) 2001-04-25 2004-06-24 Алтана Фарма Аг Новые фталазиноны
AU2003255376A1 (en) 2002-08-10 2004-03-11 Altana Pharma Ag Piperidine-derivatives as pde4 inhibitors
PL373146A1 (en) * 2002-08-10 2005-08-22 Altana Pharma Ag Pyridazinone-derivatives as pde4 inhibitors
MXPA05001354A (es) 2002-08-10 2005-04-28 Altana Pharma Ag Piperidina-ftalazonas sustituidas por pirrolidinodiona como inhibidores pde4.
EP1720854A1 (en) 2004-02-04 2006-11-15 Altana Pharma AG Phthalzinone derivatives as pde4 inhibitors
JP4778449B2 (ja) * 2004-02-04 2011-09-21 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｐｄｅ４インヒビターとしての２−（ピペリジン−４−イル）−４，５−ジヒドロ−２ｈ−ピリダジン−３−オン誘導体
CN104817534A (zh) * 2004-03-03 2015-08-05 塔科达有限责任公司 新的羟基-6-杂芳基菲啶及其作为pde4抑制剂的用途
JP4584990B2 (ja) 2004-05-18 2010-11-24 シェーリング コーポレイション Ｐｄｅ４インヒビターとして有用な置換２−キノリル−オキサゾール
PA8713501A1 (es) 2006-02-07 2009-09-17 Wyeth Corp INHIBIDORES DE 11-BETA HIDROXIESTEROIDE DEHIDROGENASA - 11ßHSD1
MY154498A (en) 2007-05-16 2015-06-30 Takeda Gmbh Pyrazolone derivatives as pde4 inhibitors
CA2692249A1 (en) 2007-06-19 2008-12-24 Yasushi Kohno Pyrazolone derivative and pde inhibitor containing the same as active ingredient
AR074318A1 (es) * 2008-11-14 2011-01-05 Nycomed Gmbh Derivados heterociclicos de pirazolona, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades de las vias respiratorias.

Also Published As

Publication number Publication date
BRPI0921335A8 (pt) 2017-12-05
CA2742922A1 (en) 2010-05-20
EA201100740A1 (ru) 2012-01-30
CN102369194A (zh) 2012-03-07
NZ593262A (en) 2013-03-28
AR074318A1 (es) 2011-01-05
ME01134B (me) 2013-03-20
KR20110082616A (ko) 2011-07-19
ECSP11011034A (es) 2011-06-30
EA018585B1 (ru) 2013-09-30
EP2356103B1 (en) 2015-08-26
ES2553754T3 (es) 2015-12-11
BRPI0921335A2 (pt) 2017-06-06
EP2356103A1 (en) 2011-08-17
US8609848B2 (en) 2013-12-17
MA32885B1 (fr) 2011-12-01
MX2011005030A (es) 2011-05-30
WO2010055083A1 (en) 2010-05-20
TWI460172B (zh) 2014-11-11
MY154019A (en) 2015-04-30
CA2742922C (en) 2018-02-27
AU2009315615A1 (en) 2011-06-30
US9340522B2 (en) 2016-05-17
TW201022228A (en) 2010-06-16
PE20110539A1 (es) 2011-08-04
ZA201102028B (en) 2011-11-30
CN102369194B (zh) 2014-08-27
JP5599405B2 (ja) 2014-10-01
JP2012508720A (ja) 2012-04-12
CO6331469A2 (es) 2011-10-20
GEP20135918B (en) 2013-09-10
UA105910C2 (ru) 2014-07-10
US20110218201A1 (en) 2011-09-08
IL212700A0 (en) 2011-07-31
US20140073672A1 (en) 2014-03-13

Similar Documents

Publication Publication Date Title
HRP20181370T1 (hr) Heterociklični spoj i njegova uporaba
IL211549A0 (en) Aminotriazolopyridines and their use as kinase inhibitors
ZA200909152B (en) Triazolopyridine compounds and their use as ask inhibitors
GB0818241D0 (en) Compounds and their use
IL208081A0 (en) Amido - thiophene compounds and their use
IL213000A0 (en) Raf inhibitors and their uses
ZA201007395B (en) Aryl-quinolyl compounds and their use
HK1137756A1 (en) Substituted dihydropyrazolones and use thereof as hif-prolyl-4 -hydroxylase inhibitors hif--4-
PL2344449T3 (pl) Związki arylo-fenylo-sulfonamido-cykloalkilowe i ich zastosowanie
IL211204A0 (en) Mucoadherents compositions and their use
HK1160925A1 (zh) 組織蛋白酶 的用途
GB0918601D0 (en) Decahydro-1H-Indenoquinolinone and decahydro-3H-cyclopenaphenanthridinone CYP17 inhibitors
EP2379076A4 (en) PHOSPHODIESTERASE HEMMER AND ITS USES
ZA201102837B (en) Phosphodiestarase inhibitors
EP2399921A4 (en) HETEROCYCLIC COMPOUND AND APPLICATIONS
HK1167406A1 (en) Pyrazolone-derivatives and their use as pd4 inhibitors pd4
IL208824A0 (en) Iminopyridine derivative and use thereof
GB0801319D0 (en) Compounds and their use
GB2461611B (en) Composition and use thereof
IL214333A0 (en) Carbamoylphosphonates as inhibitors and uses thereof
GB0802194D0 (en) Compounds and their use
GB0813254D0 (en) Compounds and their use
GB0817897D0 (en) Compounds and their use
GB0802195D0 (en) Compounds and their use II
GB0810409D0 (en) Composition and use thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20191114